Kevin L. Greason, MD, disucsses the advances in endovascular repair of thoracic aortic aneurysm.
Aneurysms affect an estimated 6 patients per 100,000 persons per year, an estimated 21,000 patients yearly in the United States. Unfortunately, these patients frequently have comorbid conditions such as chronic obstructive pulmonary disease, coronary artery disease, or renal insufficiency that can complicate [...]
Mayo Clinic mammography screening recommendations remain the same, despite revised recommendations by the U.S. Preventive Services Task Force.
Sandhya Pruthi, M.D., director of the Breast Clinic at Mayo Clinic in Rochester, and leader of the task force explains Mayo’s recommendations.
Mayo Clinic physicians and researchers state that the modeling data used in the analysis, along with [...]
Rodney Breau, M.D., a Mayo Clinic urologic oncology fellow discusses new Mayo Clinic research that studied the association between prostate-specific antigen levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. These findings were presented at the North Central Section of [...]
Dr. Daniel Elliot discusses Robot-Assisted Laparoscopic Sacrocolpopexy. This information was recently presented at the North Central Section of the American Urological Association in Scottsdale, Ariz.
ABSTRACT
INTRODUCTION: With the advent of robotic-assisted laparoscopic surgery, application of open surgical principles is increasingly translated to the minimally invasive laparoscopic approach.
OBJECTIVES: We examined the learning curve for the robot-assisted sacrocolpopexy [...]
Dr. Krowka discusses a recent presentation on Portopulmonary hypertension.
ABSTRACT
Background: Ambrisentan is a newer endothelin receptor antagonist (ERA) with potential advantages over Bosentan for the therapy of POPH: selective ERA antagonism, once-daily dosing and minimizes elevation in liver enzymes. We describe hemodynamic responses and clinical outcomes of patients with POPH treated with Ambrisentan at Mayo Clinic, [...]
Dr. Leslie Cooper Jr., discussed several new diagnostic methods, such as cardiac magnetic resonance imaging (MRI), that are useful for diagnosing myocarditis. These findings were published in the November 2009 issue of Mayo Clinic Proceedings.
Abstract
Myocarditis, an inflammatory disease of heart muscle, is an important cause of dilated cardiomyopathy worldwide. Viral infection is also an important cause of [...]
Dr. John M. Pach, M.D., of the Department of Ophthalmology and Dr. Steven A. Smith, of the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at Mayo Clinic discuss the discuss major risk factors for diabetic retinopathy including diabetes mellitus.
Dr. Pach
Dr. Smith
Read article
Dr. William Sandborn discusses a new study led by Mayo Clinic that found ulcerative colitis patients had a 41 percent reduction in colectomy after a year when treated with infliximab. This study is published in the October 2009 issue of Gastroenterology.
ABSTRACT
Background & Aims
The efficacy of infliximab for treating patients with ulcerative colitis has been established.
Methods
The [...]
Dr. Tait Shanafelt discusses a report that distress and fatigue among medical residents are independent contributors to self-perceived medical errors. The findings appear in the Journal of the American Medical Association.
ABSTRACT
JAMA. 2009;302(12):1294-1300.
Context Fatigue and distress have been separately shown to be associated with medical errors. The contribution of each factor when assessed simultaneously is [...]
This study was presented at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, on Sept. 11, 2009, and found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS). This early research holds promise for new therapies and better prediction of [...]
